Close
Patheon
Trends and Challenges in Outsourced Oral Solid Dosage Forms
Small Molecule API
Author: Anil Kane, Ph.D., MBA, Executive Director, Global Head of Technical and Scientific Affairs, Patheon
Thursday, June 15, 2017

As drug companies have fewer and fewer new compounds entering their R&D pipelines, outsourcing of development and manufacturing activities for oral solid dosage forms and sterile forms is on the rise. Pharmaceutical Technology recently spoke with Anil Kane, PhD, MBA, executive director and global head of technical and scientific affairs at Patheon, about trends and significant changes in outsourcing the manufacture and development of solid oral dosage forms.


Please complete the short form below to listen to this podcast.

Looking for Solutions?

We can help.